Clinical Trial Update: FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous ketamine with functional MRI in treatment-resistant bipolar depression. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Treatment-resistant Bipolar Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Brian Barnett | Conditions: Bipolar Depression, Treatment Resistant Bipolar Depression | Phase 2 | Status: COMPLETED